Feasibility and Preliminary Effects of Fasting-Mimicking Diet in Asian Americans with Prediabetes
Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Jul 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special diet called the Fasting-Mimicking Diet (FMD) to see if it can help Asian Americans who have prediabetes. The FMD is a carefully designed eating plan that lasts for five days, where participants consume fewer calories and specific nutrients. The main goals of the study are to find out how easy it is to recruit participants and for them to stick with the diet, and to see if this diet can lower blood sugar levels and improve other health measurements.
To participate, you need to be Asian American and diagnosed with prediabetes, which can be identified through certain blood tests. This trial is looking for all adults, but some people may not qualify, such as those with a history of diabetes or certain health conditions. Participants will try the FMD for five days, complete surveys, and attend two study visits to measure their blood sugar and other health indicators before and after the diet. This is an exciting opportunity to contribute to research that could help others manage prediabetes effectively.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Identify as Asian American
- * Diagnosed with prediabetes according to at least one of the following:
- • HbA1C 5.7%-6.4%
- • Fasting blood glucose 100 to 125 mg/dL (5.6 to 6.9 mmol/L )
- • Oral glucose tolerance test (OGTT) 140-199 mg/dL at two hours
- Exclusion criteria:
- • Individuals with a personal history of diabetes mellitus (ICD-10 codes E08-E13), cardiovascular disease, mental illness, drug dependency, pregnancy, and special dietary restrictions
- • Individuals taking insulin or insulin-like drugs and individuals taking hypoglycemic agents other than metformin
- • Individuals who are pregnant or breastfeeding
- • Individuals with anaphylaxis food allergies
- • Individuals who are allergic to tree nuts (macadamia, cashew, almond, pecan), soy, oats, sesame, or celery/celeriac
- • Individuals who have completed the FMD in the past year
About University Of California, Irvine
The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irvine, California, United States
Patients applied
Trial Officials
Hannah Lui Park, PhD
Principal Investigator
University of California, Irvine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported